Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals submits media release

09 Jul 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Ranolazine Extended?Release Tablets, 500 mg and 1,000 mg’ which is self explanatory. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..